Skip to content

KRAIG BIOCRAFT LABORATORIES, INC.

KBLB

CIK 0001413119

← back to feed
Revenue (TTM)
$401.62K
Q1 Mar 2026
Net Income (TTM)
−$4.56M
−6.6% YoY Q1 Mar 2026
EPS Diluted (TTM)
$0.00
Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
-865.9%
Q1 Mar 2026
Net Margin
-1,135.9%
Q1 Mar 2026
Free Cash Flow (TTM)
−$1.87M
Q1 Mar 2026
Cash
$2.89M
Q1 Mar 2026
Total Debt
$8.76K
Q1 Mar 2026
Shares Outstanding
1.1B sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings